AG
GBIO

Artal Group’s Generation Bio GBIO Stock Holding History

Artal Group’s Portfolio GBIO Stock Details GBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-283,059
Closed -$7.98M – 38
2024
Q2 		$7.98M Hold
283,059
– – 0.2% 47
2024
Q1 		$11.5M Buy
283,059
+1,640
+0.6% +$38.6K 0.29% 41
2023
Q4 		$4.64M Hold
281,419
– – 0.15% 54
2023
Q3 		$10.7M Hold
281,419
– – 0.46% 34
2023
Q2 		$15.5M Hold
281,419
– – 0.48% 30
2023
Q1 		$12.1M Hold
281,419
– – 0.72% 34
2022
Q4 		$11.1M Hold
281,419
– – 0.62% 39
2022
Q3 		$14.9M Hold
281,419
– – 0.64% 34
2022
Q2 		$18.5M Hold
281,419
– – 0.99% 27
2022
Q1 		$20.7M Hold
281,419
– – 0.86% 25
2021
Q4 		$19.9M Hold
281,419
– – 0.54% 47
2021
Q3 		$70.6M Hold
281,419
– – 1.58% 15
2021
Q2 		$75.7M Hold
281,419
– – 1.54% 15
2021
Q1 		$80.1M Hold
281,419
– – 1.42% 19
2020
Q4 		$79.8M Hold
281,419
– – 1.71% 16
2020
Q3 		$87M Hold
281,419
– – 2.11% 10
2020
Q2 		$59.1M Buy
+281,419
New +$62.7M 1.65% 14

Other funds holding GBIO

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Artal Group's GBIO Position: Q3 2024 in Review

Artal Group sold out of Generation Bio (GBIO) in Q3 2024, closing a stake of 283,059 shares — an estimated $7.98M sold.

Artal Group first reported a position in GBIO in Q2 2020 and held it in 17 quarters. The position peaked at $87M in Q3 2020. 75 funds tracked by Wall St. Rank hold GBIO as of Q3 2024.

  • Artal Group reported no remaining Generation Bio position as of Q3 2024 after selling out during the quarter.
  • Artal Group sold 283,059 Generation Bio shares in Q3 2024, an estimated $7.98M.
  • Artal Group first reported a position in Generation Bio in Q2 2020 and held it in 17 quarters.
  • Artal Group's Generation Bio position peaked at $87M in Q3 2020.
  • 75 funds tracked by Wall St. Rank held Generation Bio as of Q3 2024.

Based on Artal Group's 13F filing for Q3 2024, filed 13 Nov 2024.